Jiangtao Liang

Jiangtao Liang

Auto-generated profile, based on publicly available information

Jiangtao Liang

Hangzhou Universal Medical Imaging Diagnostic Center, 310009 Hangzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
JNJialing Niu
Jialing Niu
JLJiangtao Liang
Jiangtao Liang
FQFeng Qi
Feng Qi
MWMei Wang
Mei Wang
LWLuoyu Wang
Luoyu Wang
ZDZhongxiang Ding
Zhongxiang Ding
Introduction: Langerhans cell histiocytosis (LCH) is a histiocytic proliferative disease without a well-understood etiology. The aim of our study is to summarize the imaging features of PET/MR in children with LCH and to explore its diagnostic role in LCH. Methods: Retrospective analysis was performed of the pretreatment PET/MR imaging data of 15 children with LCH. Comparison of ADC values was done between lesions and normal tissues. Results: Of the fifteen patients enrolled, five had single-organ or single-system involvement, and ten had multiple-system involvement. Nine patients had varying degrees of bone destruction and increased FDG uptake, whereas thickening and deviation of the pituitary stalk and disappearance of the normal high-signal intensity of T1WI in the neurohypophysis were observed in the pituitary gland in six of them. Splenomegaly with diffuse increased FDG uptake or a normal spleen with increased FDG uptake was found in four cases, liver in three, multiple lymph node enlargement in three, pulmonary lesions in three, and increased metabolism in medullary cavity in two cases. Additionally, two cases involved the skin. Hypermetabolic nodules were detected in muscle in one case, thyroid involvement in one case, and a mediastinal lesion in one case. Conclusion: PET/MR can show well the distribution of the organs, systems, and lesions involved in LCH and is of considerable significance in the systemic evaluation of LCH.

27 September 2021 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
JWJunfeng Wang
Junfeng Wang
FWFangxiao Wang
Fangxiao Wang
YLYue Liu
Yue Liu
YXYuanfan Xu
Yuanfan Xu
JLJiangtao Liang
Jiangtao Liang
ZSZiming Su
Ziming Su
This paper provides an in-depth discussion and analysis of the estimation of nuclear medicine exposure measurements using computerized intelligent processing. The focus is on the study of energy extraction algorithms to obtain a high energy resolution with the lowest possible ADC sampling rate and thus reduce the amount of data. This paper focuses on the direct pulse peak extraction algorithm, polynomial curve fitting algorithm, double exponential function curve fitting algorithm, and pulse area calculation algorithm. The detector output waveforms are obtained with an oscilloscope, and the analysis module is designed in MATLAB. Based on these algorithms, the data obtained from six different lower sampling rates are analyzed and compared with the results of the high sampling rate direct pulse peak extraction algorithm and the pulse area calculation algorithm, respectively. The correctness of the compartment model was checked, and the results were found to be realistic and reliable, which can be used for the analysis of internal exposure data in radiation occupational health management, estimation of internal exposure dose for nuclear emergency groups, and estimation of accidental internal exposure dose. The results of the compartment model of the respiratory tract and the compartment model of the digestive tract can be used to calculate the distribution and retention patterns of radionuclides and their compounds in the body, which can be used to assess the damage of radionuclide internal contamination and guide the implementation of medical treatment.

26 June 2026 in Revista De Neurologia
Verified
Journal Article
Open access
JLJiangtao Liang
Jiangtao Liang
FLFeng Li
Feng Li
ZDZhongxiang Ding
Zhongxiang Ding
BYBing Yan
Bing Yan
YZYanfang Zhu
Yanfang Zhu
WXWeiling Xuan
Weiling Xuan
Background:This study aimed to explore the value of multiparameter imaging features of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) in predicting MYCN amplification status in children with high-risk neuroblastoma (HR-NB) and to construct a combined predictive model.Methods:A retrospective analysis of the clinical and PET/MRI imaging data of 121 children with HR-NB who were examined at our center between December 2018 and December 2025. According to the tumor MYCN amplification status, patients were divided into amplification (MNA group) and non-amplified (MYCN-NA group) groups. The differences in clinical characteristics and PET/MRI parameters between the two groups were also compared. Multivariate logistic regression analysis was used to identify the independent predictive factors. The predictive performance of each parameter and the combined model was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curves. The combined model was visualized using nomograms.Results:The imaging-defined risk factor (IDRF) positivity rate, proportion of stage M cases, and detection rates of tumor necrosis and hemorrhage were significantly higher in the MNA group than in the MYCN-NA group (all p < 0.05). The MNA group demonstrated a significantly larger mean diameter, higher maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG), and a significantly lower mean apparent diffusion coefficient (ADCmean) (all p < 0.001). Multivariate regression analysis showed that SUVmax (odds ratio (OR) = 1.71, 95% CI: 1.02–2.86, p = 0.042), MTV (OR = 1.075, 95% CI: 1.009–1.145, p = 0.026), and ADCmean (OR = 0.34, 95% CI: 0.16–0.72, p = 0.004) were independent predictors of MYCN amplification. The combined model predicted MYCN amplification with an AUC of 0.916 (95% CI: 0.867–0.965), sensitivity of 83.3%, and specificity of 81.0%, outperforming all single parameters. Calibration and decision curve analyses indicated good calibration and clinical utility of the combined model.Conclusion:The predictive model constructed by combining SUVmax, MTV, and ADCmean can noninvasively distinguish MYCN amplification status in HR-NB patients.